The aim of this project is to utilize an Offeror’s high‐performance expression AAV9 vector platform for transgene transfer that can be utilized for gene therapy for the treatment of different monogenic diseases. This project will focus on fulfilling the requirement to deliver drug product of one (1) gene to treat a specific monogenic disease. The Proposal Submission Deadline Has Been Extended to 1:00 PM (ET) January 3, 2020.
Leidos Biomedical Research, Inc.
Proposal Due Date:
Friday, January 3, 2020
Research & Development Services & Subcontracts
NCI OA Contract Number:
HHSN261201500003I - IDIQ
Offeror questions are due 1:00pm (ET) on Friday, December 6, 2019. The Proposal Submission Deadline Has Been Extended to 1:00 PM (ET) January 3, 2020. For the full solicitation package please contact Ms. Heather Housaman at Heather.Housaman@nih.gov or Ms. Shaneeka Owens at Shaneeka.Owens-Bearden@nih.gov.